Elevated Second-Trimester Maternal Serum hCG: A Marker of Inadequate Angiogenesis
โ Scribed by Catherine Y Spong MD; Alessandro Ghidini MD; Gary A Dildy MD; Carol A Loucks RN; Michael W Varner MD; John C Pezzullo PhD
- Book ID
- 117192755
- Publisher
- Lippincott Williams and Wilkins
- Year
- 1998
- Tongue
- English
- Weight
- 291 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0029-7844
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prenatal Down syndrome screening with maternal serum alpha-fetoprotein (AFP) and human chorionic gonadotrophin (hCG) has become common. High levels of maternal serum hCG and low levels of AFP have been associated with an increased risk of fetal Down syndrome. In this paper, we report five pregnancie
## Abstract Previous studies have found an association between elevated second trimester maternal serum ฮฑโfetoprotein (MSโAFP), in the absence of fetal anomalies, and adverse pregnancy outcome. We studied the association between elevated second trimester maternal serum ฮฒโHCG, now also routinely mea
In a study of 130 ยฎrst trimester cases of trisomy 21 and 959 controls we have shown that the median MoM for alpha-fetoprotein (AFP) is lower (0.82) and that for total human chorionic gonadotrophin (hCG) is higher (1.31) than in the control group. For AFP 15.3% of cases were below the 5th centile and